Industry Sponsored Symposium - What’s IL-23 Got to Do With It? Targeted Therapies in the Management of IBD
Monday, October 28, 2024
7:00 PM – 9:00 PM ET
Location: Philadelphia Marriott – Salon Ballroom H-J
Marla Dubinsky, MD (Moderator), David P. Hudesman, MD, FACG, Corey A. Siegel, MD, MS
This activity is supported by an educational grant from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.- both are Johnson & Johnson companies.
In this CME Outfitters hybrid educational symposium, expert faculty will review the functions of Fc gamma receptors, CD64 and its connection with interleukin (IL)-23, the molecular attributes of anti–IL–23 therapies, in vivo data on expression of CD64 monocytes, and the most recent clinical trial data differentiating the anti–IL-23 agents. To demonstrate these concepts, animated 3-D models will be included in the educational program and available to attendees.
Industry-Sponsored Satellite Symposia provide additional educational opportunities for attendees. These programs are independent of the ACG 2024 Annual Scientific Meeting and Postgraduate Course programs. The ACG is not the continuing medical education provider of these programs. For more information, see the company sponsor.
Use the Register button or register at link www.cmeoutfitters.com/IL23MM